CNS Pharmaceuticals, Inc. (CNSP)

Last Closing Price: 3.92 (2026-11-19)

Cash Flow from Financial Activities (Quarterly)

Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.

CNS Pharmaceuticals, Inc. (CNSP) had Cash Flow from Financial Activities of $20.98M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-2.50M
--
--
$2.67M
$-2.67M
$0.17M
$-2.50M
$-2.50M
$-2.50M
$-2.50M
$-2.50M
$-2.50M
$-2.67M
$-2.67M
10.61M
10.61M
$-0.24
$-0.24
Balance Sheet Financials
$18.05M
$0.01M
$0.01M
$18.06M
$2.36M
--
--
$2.36M
$15.71M
$15.71M
$15.71M
1.48M
Cash Flow Statement Financials
$-10.96M
$-0.01M
Cash Flow from Financial Activities
$20.98M
$7.20M
$17.21M
$10.01M
$0.03M
--
--
Fundamental Metrics & Ratios
7.65
--
--
--
--
--
--
--
--
--
--
$-10.97M
--
--
--
--
--
--
--
-15.91%
-15.91%
-13.83%
-15.91%
$10.64
$-1.03
$-1.03